Form 8-K BioPharmX Corp For: Nov 20
StreetInsider.com
On November 24, 2017, BioPharmX Corporation (the “Company”) issued warrants to purchase up to an aggregate of 73,500,000 shares of Common Stock (the “Existing Warrants”) with an exercise price per share of $0.25. The Existing Warrants were …
